On March 1, 2012, Tibet Pharmaceuticals, Inc. (the “Company”) issued a press release announcing that its Board of Directors (the “Board”) has received a non-binding letter from its Chairman and Chief Executive Officer, Mr. Hong Yu (“Mr. Yu”) dated March 1, 2012, pursuant to which Mr. Yu proposes subject to certain conditions to acquire all of the outstanding shares of common stock of the Company in cash at $3 per share which represents a premium over the current stock price (the “Proposal”). The Proposal is both non-binding and subject to certain conditions.
http://google.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=8452845-1008-5619&type=sect&TabIndex=2&companyid=828647&ppu=%252fdefault.aspx%253fsym%253dTBET
follow me on THE BLUE EXCHANGE
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM